English ▼
Arabic
Chinese
German
French
Spanish
Portuguese
Vietnamese
Korean
Urdu (Pakistan)
Tagalog (Phillipines)
Hausa (Nigeria)Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent
(OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
Florida Lawmakers Attempt to Pass Legislation Regulating Pharmacy Benefit Managers
In recent years, the role of pharmacy benefit managers (PBMs) occupy has grown significantly. However, as their role—and power that comes along with it—grows, the regulation of PBMs has been slow to follow. In fact, PBMs are not regulated on the federal level, and many states stay out of the...
Read moreWhat Is the Worst-Case Scenario in a DEA Pharmacy Audit?
When the DEA Audits a Pharmacy, it has One Goal in Mind: To Uncover Any Statutory or Regulatory Violations So that They Can Be Penalized Appropriately. When agents from the U.S. Drug Enforcement Administration (DEA) show up at your pharmacy and start asking questions, what is at risk? Is it...
Read more
CBD Compliance for Pharmacists
More patients are coming to you every day asking about CBD oil and other cannabis-based treatments and medications. Here’s what you need to know in order to maintain federal compliance. When the federal Agriculture Improvement Act of 2018 (commonly known as the “Farm Bill”) was passed late last year, hemp...
Read more
How Can Pharmacists Be Charged with Prescription Drug Fraud?
Pharmacists are currently at high risk for being targeted in Federal Healthcare Fraud investigations. If your pharmacy or compound pharmacy is under investigation, we can help. When you went to pharmacy school, the last thing on your mind was the risk of being targeted in a federal investigation. As you...
Read more
What Is the Prescription Interdiction & Litigation (PIL) Task Force?
The Prescription Interdiction & Litigation (PIL) Task Force is one of the DOJ's newest efforts to target healthcare providers as it seeks to combat the nation's opioid crisis. Earlier this year, the U.S. Department of Justice (DOJ) announced the formation of a new Prescription Interdiction & Litigation (PIL) Task Force....
Read more